Telomerase reverse transcriptase inhibition stimulates cyclooxygenase 2 expression in cancer cells and synergizes with celecoxib to exert anti-cancer effects

BACKGROUND: Telomerase and telomerase reverse transcriptase (hTERT) confer cancer cells sustained proliferation and survival potentials. Targeting telomerase or hTERT is a novel anti-cancer strategy. However, telomerase/hTERT inhibition alone has minimal clinical efficacy. We explored the relationsh...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, T, Liang, X, Li, B, Björkholm, M, Jia, J, Xu, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681031/
https://www.ncbi.nlm.nih.gov/pubmed/23681187
http://dx.doi.org/10.1038/bjc.2013.208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681031/
https://www.ncbi.nlm.nih.gov/pubmed/23681187
http://dx.doi.org/10.1038/bjc.2013.208

Ejemplares similares